Evidence map›Paper›PMID 26137002›Full record

ArticleOncology letters2015

Neurokinin-2 receptor polymorphism predicts lymph node metastasis in colorectal cancer patients.

Weijia Fang, Caiyun Fu, Xiaogang Chen, Xiaozhou Mou, Fanlong Liu, Jiong Qian, Peng Zhao, Yulong Zheng, Y I Zheng, Jing Deng and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Weijia FangBiotherapy Center, Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Caiyun FuLab of Proteomics and Molecular Enzymology, School of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, Zhejiang 310018, P.R. China ; Institute for Cell-based Drug Development of Zhejiang Province, Hangzhou, Zhejiang 310058, P.R. China.
Xiaogang ChenBiotherapy Center, Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Xiaozhou MouBiotherapy Center, Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China ; Institute for Cell-based Drug Development of Zhejiang Province, Hangzhou, Zhejiang 310058, P.R. China.
Fanlong LiuBiotherapy Center, Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Jiong QianBiotherapy Center, Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Peng ZhaoBiotherapy Center, Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Yulong ZhengBiotherapy Center, Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Y I ZhengBiotherapy Center, Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Jing DengBiotherapy Center, Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Pingjiang YeDepartment of Anorectum, People's Hospital of Shaoxing, Shaoxing, Zhejiang 312000, P.R. China.
Yifei WangSecond People's Hospital of Jiaxing, Jiaxing, Zhejiang 314000, P.R. China.
Shusen ZhengBiotherapy Center, Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.
Zhejiang University · CNFirst Hospital of Jiaxing · CNShaoxing People's Hospital · CNZhejiang Sci-Tech University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To analyze the single nucleotide polymorphisms (SNPs) of two subtypes of neurokinin (NK) receptors,

Indexed as

colorectal cancerneurokinin 2 receptorpositive lymph nodesingle nucleotide polymorphisms

Identifiers

PMID26137002
PMCPMC4467290
OpenAlexW2155797935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.